(Globes) Israel's CorNeat Vision has completed the design and development stage of its artificial cornea implant. Following successful trials in rabbits, the company is initiating formal biocompatibility and safety tests toward first implantation in humans by mid-2018. The implant is a synthetic cornea that utilizes advanced cell technology to integrate artificial optics within resident ocular tissue. The cornea is produced using nanoscale chemical engineering that stimulates cellular growth. It leverages a virtual space under the conjunctiva that is rich with fibroblast cells that heal quickly and provide robust long-term integration.
2017-10-10 00:00:00Full ArticleBACK Visit the Daily Alert Archive